Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Western Chemical is a leading provider of FDA-approved pharmaceutical products and specialty chemicals dedicated to the aquaculture and fisheries management sectors. Founded in 1976 and headquartered in Ferndale, Washington, the company specializes in anesthetics, disinfectants, and therapeutic treatments for aquatic species. Its flagship products include MS-222 (tricaine methanesulfonate), the only anesthetic approved by the FDA for use in food fish, and Parasite-S (formalin). Following its acquisition by Syndel in 2015, the company continues to operate as a key brand within the global aquatic health market. Western Chemical remains a critical partner for government agencies, commercial hatcheries, and academic institutions involved in fish conservation and production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Western Chemical.